Characteristics of xpert MTB/RIF-negative patients with pulmonary tuberculosis

Clinical Infectious Diseases

Volumn 55, Issue 3, 2012, Pages 472-473

  Theron, Grant ^a   Peter, Jonny ^a   Dheda, Keertan ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; BACTERIAL LOAD; BACTERIUM CULTURE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIQUID CULTURE; LUNG TUBERCULOSIS; PRIORITY JOURNAL; SPUTUM ANALYSIS; THORAX RADIOGRAPHY;

FALSE NEGATIVE REACTIONS; FEMALE; HIV INFECTIONS; HUMANS; MALE; TUBERCULOSIS, PULMONARY;

EID: 84863962291     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis465     Document Type: Letter

References (5)

1. Lawn SD, Kerkhoff AD, Vogt M, Ghebrekristos Y, Whitelaw A, Wood R. Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy. Clin Infect Dis 2012; 54:1071-9.
2. Theron G, Peter J, van Zyl-Smit R, et al. Evaluation of the Xpert (R) MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011; 184:132-40.
3. Theron G, Pooran A, Peter J, et al. Do adjunct TB tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? EurRespir J 2011; doi:10.1183/09031936.00145511.
4. Theron G, Peter J, Dheda K. Xpert MTB/RIF test for tuberculosis. Lancet 2011; 378:481.
5. Dheda K, Lampe FC, Johnson MA, Lipman MC. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 2004; 190:1670.